annual Report 2009 - STRATEC Biomedical AG

Report of the board of Management
Report of the supervisory board
THE share
Corporate Governance
Group Management report
Consolidated financial statements
Service
(11) Securities
Pursuant to IAS 39, shares in listed companies have been allocated to the “Financial assets held for trading” category and
measured at fair value. These amounted to u 654 thousand at the balance sheet date (previous year: u 293 thousand).
The fair values are recognized through profit or loss in the statement of comprehensive income. The measurement as
of the balance sheet date resulted in price-related gains of u 361 thousand (previous year: losses of u -131 thousand),
which have been recognized under other financial income/expenses. As in 2008, there were no additions or disposals
in the 2009 financial year. In view of their denomination in euros, the securities were not subject to any foreign currency
risk. Were the stock market prices to rise (fall) by 10 % compared with the balance sheet date, then this would increase
(reduce) consolidated earnings by u 65 thousand (previous year: u 29 thousand).
(12) Cash and cash equivalents
Cash and cash equivalents include cash holdings and credit balances at banks with terms of less than three months.
In view of the short terms involved, it was not necessary to undertake any adjustments due to interest rate fluctuations
as of the balance sheet date. The translation of foreign currency credit balances at foreign group companies resulted in
currency translation differences of u 12 thousand (previous year: u 202 thousand). These have been recognized directly
in equity. Furthermore, the measurement of US dollar holdings at the balance sheet date led to a non-cash increase in
cash holdings (through profit or loss) by u 57 thousand (previous year: reduction of u -190 thousand).
The other non-cash income and expenses neutralized in the calculation of the cash flow from operating activities in the
cash flow statement largely related to the following income and expense items:
in v thousand 2009 2008
Expenses
Currency translation losses from measurement of cash holdings at balance sheet date 0 190
Personnel expenses in connection with the granting of stock option rights 220 164
Currency translation differences on receivables denominated in foreign currencies 22 9
Receivables defaults 32 0
Increase in allowances recognized for inventories 54 0
Expenses from fair value measurement of securities held for trading 0 131
Impairment losses from fair value measurement of financial assets available for sale 0 2,075
Currency translation differences on prepayments received for inventories 33 0
Miscellaneous expenses 0 9
Total 361 2,578
in v thousand 2009 2008
Income
Currency translation gains from measurement of cash holdings at balance sheet date 57 0
Reduction in allowances recognized on receivables 57 17
Income from disposal
(previous year: from fair value measurement) of derivative financial liabilities 0 63
Income from fair value measurement of securities held for trading 361 0
Income from reversal of other provisions and liabilities 29 463
Income on own work capitalized 625 456
1,129 999
Net balance of additions (+) / deductions (-) -768 1,579
stratec Annual Report 2009
75